Hyponatremia: Prolonged use of the vasopressin antagonist tolvaptan is a safe and effective treatment for hyponatremia

被引：0
|
作者：
Ireland R.
机构：
来源：
Nature Reviews Nephrology | 2010年 / 6卷 / 6期
关键词：
D O I：
10.1038/nrneph.2010.61
中图分类号：
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：315 / 315
相关论文
共 50 条
  • [1] Tolvaptan, an oral vasopressin antagonist, in the treatment of hyponatremia in cirrhosis
    Cardenas, Andres
    Gines, Pere
    Marotta, Paul
    Czerwiec, Frank
    Oyuang, John
    Guevara, Monica
    Afdhal, Nezam H.
    JOURNAL OF HEPATOLOGY, 2012, 56 (03) : 571 - 578
  • [2] Oral Tolvaptan Is Safe and Effective in Chronic Hyponatremia
    Berl, Tomas
    Quittnat-Pelletier, Friederike
    Verbalis, Joseph G.
    Schrier, Robert W.
    Bichet, Daniel G.
    Ouyang, John
    Czerwiec, Frank S.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2010, 21 (04): : 705 - 712
  • [3] Chronic hyponatremia impairs memory in rats: effects of vasopressin antagonist tolvaptan
    Miyazaki, Toshiki
    Ohmoto, Koji
    Hirose, Tsuyoshi
    Fujiki, Hiroyuki
    JOURNAL OF ENDOCRINOLOGY, 2010, 206 (01) : 105 - 111
  • [4] Lixivaptan: a vasopressin receptor antagonist for the treatment of hyponatremia
    Rosner, Mitchell H.
    KIDNEY INTERNATIONAL, 2012, 82 (11) : 1154 - 1156
  • [5] Effects of tolvaptan, an oral vasopressin V2 receptor antagonist, in hyponatremia
    Madias, Nicolaos E.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2007, 50 (02) : 184 - 187
  • [6] Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia
    Schrier, Robert W.
    Gross, Peter
    Gheorghiade, Mihai
    Berl, Tomas
    Verbalis, Joseph G.
    Czerwiec, Frank S.
    Orlandi, Cesare
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (20): : 2099 - 2112
  • [7] Review of Tolvaptan in the Treatment of Hyponatremia
    Garcha, Amarinder S.
    Khanna, Apurv
    CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2011, 3 : 315 - 325
  • [8] Update on tolvaptan for the treatment of hyponatremia
    Dasta, Joseph F.
    Chiong, Jun R.
    Christian, Rudell
    Friend, Keith
    Lingohr-Smith, Melissa
    Lin, Jay
    Cassidy, Irving B.
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2012, 12 (04) : 399 - 410
  • [9] Tolvaptan: a new tool for the effective treatment of hyponatremia in psychotic disorders
    Josiassen, Richard C.
    Curtis, Jessica
    Filmyer, Dawn M.
    Audino, Brett
    Skuban, Nina
    Shaughnessy, Rita A.
    EXPERT OPINION ON PHARMACOTHERAPY, 2010, 11 (04) : 637 - 648
  • [10] USE OF CONIVAPTAN AND TOLVAPTAN FOR THE TREATMENT OF HYPONATREMIA IN CRITICALLY ILL ADULTS
    Der-Nigoghossian, Caroline
    Lesch, Christine
    Berger, Karen
    CRITICAL CARE MEDICINE, 2014, 42 (12)
12345